RxDoctor Payments Data

Timothy Trotter, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Oklahoma City, OKNPI 1285602532

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $436 of the $485 with a category attached, or 89.9%. It is spread thinly across 12 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $264 and has fallen 92.4% since, to $20 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in OK, where the typical reported total is $3,130.

$485in general payments, 2019–2025

Across 20 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • La Jolla Pharmaceutical Company$108
  • Surmodics, Inc.$85
  • Hemosonics LLC$76
  • Zimmer Biomet$61
  • Baxter Healthcare$33
  • Chiesi USA, Inc.$25
  • plus $98 from 6 others

What the payments were for

  • Food & beverage$43690%
  • Education$4910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$485 in reported general payments places this provider in the 20th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma

Medicare billing

Part B allowed, 2024
$50,382
Medicare patients
77
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate40$262
Furosemide13$26

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →